Advertisement
Screener

PHARMACYTE BIOTECH, INC. (PMCB) Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount

1.2 / 5 stars · 13/53 Roast Me

PHARMACYTE BIOTECH, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount

PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $0 for the 12-month period ending 2017-04-30, per its 10-K filed 2017-07-27.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2017-07-27

  • PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
  • PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2016 was $195.21K, a 91.65% decline from fiscal 2015.
  • PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2015 was $2.34M, a 74.19% decline from fiscal 2014.
  • PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2014 was $9.06M, a 2503.90% increase from fiscal 2013.
Period endEffective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month
2017-04-30$0.00
10-K · filed 2017-07-27
2016-04-30$195.21K
10-K · filed 2017-07-27
2015-04-30$2.34M
10-K · filed 2016-07-29
2014-04-30$9.06M
10-K · filed 2016-07-29
2013-04-30$348.06K
10-K/A · filed 2016-01-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70